Delayed Benefit From Aggressive Immunotherapy in Waxing and Waning Anti-IgLON5 Disease

Neurol Neuroimmunol Neuroinflamm. 2021 May 13;8(4):e1009. doi: 10.1212/NXI.0000000000001009. Print 2021 Jul.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Autoimmune Diseases of the Nervous System / diagnosis
  • Autoimmune Diseases of the Nervous System / drug therapy*
  • Autoimmune Diseases of the Nervous System / immunology
  • Autoimmune Diseases of the Nervous System / physiopathology
  • Cell Adhesion Molecules, Neuronal / immunology*
  • Encephalitis / diagnosis
  • Encephalitis / drug therapy*
  • Encephalitis / immunology
  • Encephalitis / physiopathology
  • Female
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / pharmacology*
  • Middle Aged

Substances

  • Cell Adhesion Molecules, Neuronal
  • IgLON5 protein, human
  • Immunologic Factors